Analyst
Odo BHF
Equibles does not estimate personal net worth.
Florence Espedès is recorded as Analyst at Odo BHF. Florence Espedès has spoken on 2 earnings calls across 2 companies, most recently for Sanofi on October 30, 2026. Those appearances were for Sanofi (SNY) and Novartis AG (NVS). The companies whose calls Florence Espedès spoke on are classified in the Healthcare sector.
“The first for Belen on the collaboration with Regeneron, as you announced that you could acquire late-stage products, or eventually products already on the market, so could you consider at some point, if you acquire a company with a product already inflammation on the market, to ask Regeneron if they're interested to…”
“Now, the Orion 4 results are expected by the end of this year. Could you come back on why it is earlier? It's even driven. And also, could you remind us what kind of profile there is for this product, and if the results are positive, is it fair to assume an acceleration of the sales next year for this product?”
Odo BHF
Analyst
Transcript header (unverified)
SNY
Drug Manufacturers - General · Healthcare
NVS
Drug Manufacturers - General · Healthcare
